Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Momir Bosiljcic

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Scientific Reports|October 14, 2016
A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway diseaseMark Bazett, Agnieszka Biala, Ryan D Huff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2017
2-<sup>18</sup>F-Fluoroethanol Is a PET Reporter of Solid Tumor PerfusionBrennan J Wadsworth, Jinhe Pan, Iulia Dude, et al.
Cancer Research|July 14, 2011
Myeloid suppressor cells regulate the lung environment--letterMomir Bosiljcic, Melisa J Hamilton, Judit P Banath, et al.
Respiratory Research|May 17, 2017
Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammationMark Bazett, Agnieszka Biala, Ryan D Huff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 29, 2013
Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomasMelisa J Hamilton, Momir Bosiljcic, Nancy E Lepard, et al.
Oncotarget|December 20, 2015
SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c miceMelisa J Hamilton, Elizabeth C Halvorsen, Nancy E LePard, et al.
Scientific Reports|April 5, 2020
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathologyShirin Kalyan, Mark Bazett, Ho Pan Sham, et al.
Oncoimmunology|February 6, 2018
Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapyMark Bazett, Amanda M Costa, Momir Bosiljcic, et al.
Breast Cancer Research : BCR|September 7, 2019
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungsMomir Bosiljcic, Rachel A Cederberg, Melisa J Hamilton, et al.
Frontiers in Immunology|October 16, 2018
Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative ColitisHo Pan Sham, Mark Bazett, Momir Bosiljcic, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|October 14, 2016
A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway diseaseMark Bazett, Agnieszka Biala, Ryan D Huff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2017
2-<sup>18</sup>F-Fluoroethanol Is a PET Reporter of Solid Tumor PerfusionBrennan J Wadsworth, Jinhe Pan, Iulia Dude, et al.
Cancer Research|July 14, 2011
Myeloid suppressor cells regulate the lung environment--letterMomir Bosiljcic, Melisa J Hamilton, Judit P Banath, et al.
Respiratory Research|May 17, 2017
Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammationMark Bazett, Agnieszka Biala, Ryan D Huff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 29, 2013
Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomasMelisa J Hamilton, Momir Bosiljcic, Nancy E Lepard, et al.
Oncotarget|December 20, 2015
SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c miceMelisa J Hamilton, Elizabeth C Halvorsen, Nancy E LePard, et al.
Scientific Reports|April 5, 2020
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathologyShirin Kalyan, Mark Bazett, Ho Pan Sham, et al.
Oncoimmunology|February 6, 2018
Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapyMark Bazett, Amanda M Costa, Momir Bosiljcic, et al.
Breast Cancer Research : BCR|September 7, 2019
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungsMomir Bosiljcic, Rachel A Cederberg, Melisa J Hamilton, et al.
Frontiers in Immunology|October 16, 2018
Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative ColitisHo Pan Sham, Mark Bazett, Momir Bosiljcic, et al.
Pageof 2